August 18, 2017
A novel scoring model may help predict the risk for major bleeding in patients who use antiplatelet agents after transient ischemic attack or ischemic stroke, according to findings published in Neurology.
“Prediction of bleeding risk based on patient characteristics may help physicians to balance benefits and risks of antiplatelet therapy for individual patients,” Nina A. Hilkens, MD,
from the Julius Center for Health Sciences and Primary Care at the University Medical Center Utrecht in the Netherlands, and colleagues wrote. “A recent systematic review showed that a limited number of prediction models are available for prediction of bleeding in patients on antiplatelet therapy for secondary prevention.”